The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8404487 B1

PDF
Full Text
Expired
Date of Patent:
Mar. 26, 2013

Filed:

Feb. 26, 2008
Applicants:

Carolyn E. Mountford, Easy Ryde, AU;

Peter Russell, Pyme, AU;

Ian C. P. Smith, Winnipeg, CA;

Rajmund L. Somorjai, Headingley, CA;

Inventors:

Carolyn E. Mountford, Easy Ryde, AU;

Peter Russell, Pyme, AU;

Ian C. P. Smith, Winnipeg, CA;

Rajmund L. Somorjai, Headingley, CA;

Assignee:

Other;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/48 (2006.01); G06F 19/00 (2006.01); A61B 5/05 (2006.01);
U.S. Cl.
CPC ...
Abstract

Robust classification methods analyse magnetic resonance spectroscopy (MRS) data (spectra) of fine needle aspirates taken from breast tumors. The resultant data when compared with the histopathology and clinical criteria provide computerized classification-based diagnosis and prognosis with a very high degree of accuracy and reliability. Diagnostic correlation performed between the spectra and standard synoptic pathology findings contain detail regarding the pathology (malignant versus benign), vascular invasion by the primary cancer and lymph node involvement of the excised axillary lymph nodes. The classification strategy consisted of three stages: pre-processing of MR magnitude spectra to identify optimal spectral regions, cross-validated Linear Discriminant Analysis, and classification aggregation via Computerised Consensus Diagnosis. Malignant tissue was distinguished from benign lesions with an overall accuracy of 93%. From the same spectrum, lymph node involvement was predicted with an accuracy of 95% and tumor vascularization with an overall accuracy of 92%.


Find Patent Forward Citations

Mountford, Carolyn. (2013). Magnetic resonance spectroscopy of breast biopsy to determine pathology, vascularization and nodal involvement (U.S. Patent No. 8404487). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8404487

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…